Dr. John Winkelman On Treating Sleep Disorders
John W. Winkelman, M.D., Ph.D.
Assistant Professor of Psychiatry, Harvard Medical School
Medical Director, Sleep Health Center, Brigham & Women’s Hospital
Dr. Winkelman has disclosed that he has received research grants from Boehringer- Ingelheim, GlaxoSmithKline, Pfizer, UCB Pharma, and Xenoport, that he has served as a consultant for Boehringer-Ingelheim, Cephalon, GlaxoSmithKline, Pfizer, Sanofi, and Sepracor,, and is a member of the speakers bureau of Cephalon, Eli Lilly, GlaxoSmithKline, and Sanofi.
Adele Viguera, M.D.
Assistant Professor of Psychiatry, Harvard Medical School
Associate Director, Perinatal and Reproductive Psychiatry Program,
Massachusetts General Hospital
Dr. Viguera has disclosed that she is a member of the speakers bureau of GlaxoSmithKline.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747)



